| Development Path |
2021
In April, Tiangu pharmaceutical obtained the food production license
In June, Tiangu Pharmaceutical was named as the third batch of expert workstations in Chenggu County
In October, Tiangu pharmaceutical obtained the toxic drug production license
In December, The annual operating income of Tiangu pharmaceutical was 415 million yuan
2020
In January, The marketing center of Tiangu Pharmaceutical was set up on the 16th floor of Jinshi Bilang in Xi 'an city to start marketing
In September, the project construction of Tiangu pharmaceutical factory in Chenggu County, Hanzhong city was completed and trial production began
In October, Tiangu pharmaceutical obtained the drug production license and passed the GMP certification.The production line is up and running
2019
In October, Tiangu pharmaceutical obtained the registration form for foreign trade operators
In December, the registered capital of Tiangu Pharmaceutical increased from 30 million yuan to 70 million yuan
2018
In December, Tiangu pharmaceutical successfully listed provincial enterprise technology center
2017
In October, Shaanxi Tiangu Biotechnology Group Co., Ltd. set up a wholly-owned subsidiary shaanxi Tiangu Pharmaceutical Co., LTD., with a registered capital of 30 million yuan
2015
China shaanxi Nuclear Industry Group has strategically positioned medical services and biotechnology as the group's five major industry segments, conforming to the trend of global health industry development in the new century
